Cell and Gene Therapy Manufacturing Services Market Size, Share, Impressive Industry Growth, Report 2027

 

The global cell and gene therapy manufacturing services market is anticipated to grow significantly at a CAGR of nearly 11.5% over the forecast period (2021-2027). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, in 2021, Charles River Laboratories acquired a cell & gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices. The acquisition was intended to increase its cell and gene therapy manufacturing capabilities.

A full report of Cell and Gene Therapy Manufacturing Services Market is available at: https://www.omrglobal.com/industry-reports/cell-and-gene-therapy-manufacturing-services-market

In addition to this, in 2021, Thermo Fisher Scientific Inc. acquired Henogen S.A., Novasep's viral vector manufacturing business in Belgium, for approximately $859.7 million. This acquisition is expected to increase its presence in the cell & gene therapy manufacturing therapy market. Further, in 2019, Thermo Fisher Scientific Inc. acquired Brammer Bio, a company involved in viral vector manufacturing for gene and cell therapies, for $1.7 billion.

Apart from this, FUJIFILM Cellular Dynamics opened a $21 million cGMP production facility to support its internal cell therapeutics pipeline, as well as serve as a CDMO for iPS cell products in 2021. Further, Anemocyte announced itself as the first BMO (Biotech Manufacturing Organization) in the field of cell and gene therapies. In addition to building 2000 sq. meters of GMP and GMP-compliant facilities for the production of ATMP’s, its FLYn’ICE project is using drones equipped with cryogenic pods to achieve temperature-controlled transit of cell and gene therapies.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/cell-and-gene-therapy-manufacturing-services-market

Market Coverage

·        The market number available for – 2020-2027

·        Base year- 2020

·        Forecast period- 2021-2027

·        Segment Covered- by Therapy, Scale, Indication, and End-User.

·        Regions Covered- North America, Europe, Asia-Pacific, Rest of the World

·        Competitive Landscape- Thermo Fisher Inc, Merck KGaA, and F. Hoffmann-La Roche Ltd. among others.

Key questions addressed by the report

·        What is the market growth rate?

·        Which segment and region dominate the market in the base year?

·        Which segment and region will project the fastest growth in the market?

·        How COVID-19 impacted the market?

o             Deviation from the pre-COVID-19 forecast

o             Most affected region and segment

·        Who is the leader in the market?

·        How players are addressing challenges to sustain growth?

·        Where is the investment opportunity?

Global Cell and Gene Therapy Manufacturing Services Market – Segmentation

By Therapy

·        Cell Therapy

·        Gene Therapy

By Scale

·        Pre-commercial/ R&D Scale Manufacturing

·        Commercial Scale Manufacturing

By Indication

·        Cancer

·        CVD

·        Orthopedic

·        Infectious Diseases

·        Others

By End-User

·        Pharmaceutical and Biotechnology Companies

·        Academic and Research Institutes

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/cell-and-gene-therapy-manufacturing-services-market

Cell and Gene Therapy Manufacturing Services Market– Segment by Region

North America          

·        United States

·        Canada

Europe

·        Germany

·        United Kingdom

·        France

·        Spain

·        Italy

·        Rest of Europe

Asia-Pacific   

·        China

·        Japan

·        India

·        Rest of Asia-Pacific

Rest of the World

·        Middle East & Africa

·        Latin America

Company Profiles

·        bluebird bio, Inc.

·        Boehringer Ingelheim International GmbH

·        Catalent, Inc.

·        Cell and Gene Therapy Catapult

·        Innovative Cellular Therapeutics Co., Ltd.

·        Charles River Laboratories International, Inc.

·        F. Hoffmann-La Roche Ltd.

·        FUJIFILM Holdings Corp.

·        Miltenyi Biotec B.V. & Co. KG

·        Nikon CeLL innovation Co., Ltd.

·        Novartis AG

·        Oxford Biomedica plc

·        Samsung Biologics

·        Takara Bio Inc.

·        WuXi AppTec Co., Ltd.

Reasons to Buying From us –

1.      We cover more than 15 major industries, further segmented into more than 90 sectors.

2.      More than 120 countries are for analysis.

3.      Over 100+ paid data sources mined for investigation.

4.      Our expert research analysts answer all your questions before and after purchasing your report.

 

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit Orion Market Research

 

Media Contact:

Contact Person: Mr. Anurag Tiwari

Email: anurag@omrglobal.com

Contact no: +91 780-304-0404

Company Name: Orion Market Research